Cleveland BioLabs and Incuron Announce Poster Presentation at 2013 ASCP …

Published September 15, 2013

Cleveland BioLabs and Incuron Announce Poster Presentation at 2013 ASCP …
The Company's lead compound is being developed as both a radiation countermeasure and a cancer treatment. The Company has two operating subsidiaries, Incuron, LLC, and Panacela Labs, Inc., and strategic relationships with the Cleveland Clinic, … Read more on NASDAQ

Biotech NovelMed marches toward the clinic with a new therapy for rare blood …
Having received the first installment of a $ 1.43 million SBIR grant from the National Institutes of Health, a Cleveland-based biotech is hoping for clinical trials next year for its new therapeutic for patients with a rare blood disease called … Read more on MedCity News